FREE ARCHIVE 2011

  • REVEW: Siân E Piret and Rajesh V Thakker
  • Mouse models for inherited endocrine and metabolic disorders
  • Journal of Endocrinology 211 211–230 (December 2011)
  • REVEW: Dagmara Rusinek, Sylwia Szpak-Ulczok, and Barbara Jarzab
  • Gene expression profile of human thyroid cancer in relation to its mutational status
  • Journal of Molecular Endocrinology 47 R91–R103 (December 2011)
  • THEMATIC REVEW: E J Mackie, L Tatarczuch, and M Mirams
  • The skeleton: a multi-functional complex organ. The growth plate chondrocyte and endochondral ossification
  • Journal of Endocrinology 211 109–121 (November 2011)
  • THEMATIC REVEW: Anyonya R Guntur and Clifford J Rosen
  • The skeleton: a multi-functional complex organ. New insights into osteoblasts and their role in bone formation: the central role of PI3Kinase
  • Journal of Endocrinology 211 123–130 (November 2011)
  • THEMATIC REVEW: David J Mellis, Cecile Itzstein, Miep H Helfrich, and Julie C Crockett
  • The skeleton: a multi-functional complex organ. The role of key signalling pathways in osteoclast differentiation and in bone resorption
  • Journal of Endocrinology 211 131–143 (November 2011)
  • REVEW: Marie Schaeffer, David J Hodson, Chrystel Lafont, and Patrice Mollard
  • Endocrine cells and blood vessels work in tandem to generate hormone pulses
  • Journal of Molecular Endocrinology 47 R59–R66 (October 2011)
  • REVEW: Elena Ivanova and Gavin Kelsey
  • Imprinted genes and hypothalamic function
  • Journal of Molecular Endocrinology 47 R67–R74 (October 2011)
  • REVEW: Verónica García-Carpizo, Lidia Ruiz-Llorente, Mario Fraga, and Ana Aranda
  • The growing role of gene methylation on endocrine function
  • Journal of Molecular Endocrinology 47 R75–R89 (October 2011)
  • REVEW: Caitlin Bourque and Yariv Houvras
  • Hooked on zebrafish: insights into development and cancer of endocrine tissues
  • Endocrine-Related Cancer 18 R149–R169 (October 2011)
  • REVEW: Hong-Jun Song, Yan-Li Xue, Yan-Hong Xu, Zhong-Ling Qiu, and Quan-Yong Luo
  • Rare metastases of differentiated thyroid carcinoma: pictorial review
  • Endocrine-Related Cancer 18 R165–R174 (October 2011)
  • REVEW: Changmeng Cai and Steven P Balk
  • Intratumoral androgen biosynthesis in prostate cancer pathogenesis and response to therapy
  • Endocrine-Related Cancer 18 R175–R182 (October 2011)
  • REVEW: Scott M Dehm and Donald J Tindall
  • Alternatively spliced androgen receptor variants
  • Endocrine-Related Cancer 18 R183–R196 (October 2011)
  • COMMENTARY: Anna Krook
  • A balancing act of optimising insulin dose and insulin sensitivity in type 1 diabetes
  • Journal of Endocrinology 211 1–2 (October 2011)
  • REVIEW: Gavin P Vinson
  • The mislabelling of deoxycorticosterone: making sense of corticosteroid structure and function
  • Journal of Endocrinology 211 3–16 (October 2011)
  • REVIEW: George Schlossmacher, Adam Stevens, and Anne White
  • Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells
  • Journal of Endocrinology 211 17–25 (October 2011)
  • THEMATIC REVIEW: D S Boeldt, F X Yi, and I M Bird
  • eNOS activation and NO function: Pregnancy adaptive programming of capacitative entry responses alters nitric oxide (NO) output in vascular endothelium–new insights into eNOS regulation through adaptive cell signaling
  • Journal of Endocrinology 210 243–258 (September 2011)
  • THEMATIC REVIEW: Charles A Ducsay andDean A Myers
  • eNOS activation and NO function: Differential control of steroidogenesis by nitric oxide and its adaptation with hypoxia
  • Journal of Endocrinology 210 259–269 (September 2011)
  • THEMATIC REVIEW: Ruslan Rafikov, Fabio V Fonseca, Sanjiv Kumar, Daniel Pardo, Charles Darragh, Shawn Elms, David Fulton, and Stephen M Black
  • eNOS activation and NO function: Structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity
  • Journal of Endocrinology 210 271–284 (September 2011)
  • REVIEW: Kenneth Siddle
  • Signalling by insulin and IGF receptors: supporting acts and new players
  • Journal of Molecular Endocrinology 47 R1–R10 (August 2011)
  • REVIEW: Antonella Barreca, Elena Lasorsa, Ludovica Riera, Rodolfo Machiorlatti, Roberto Piva, Maurilio Ponzoni, Ivo Kwee, Francesco Bertoni, Pier Paolo Piccaluga, Stefano A Pileri, Giorgio Inghirami, and The European T-Cell Lymphoma Study Group
  • Anaplastic lymphoma kinase in human cancer
  • Journal of Molecular Endocrinology 47 R11–R23 (August 2011)
  • REVIEW: Masaki Shiota, Akira Yokomizo, and Seiji Naito
  • Increased androgen receptor transcription: a cause of castration-resistant prostate cancer and a possible therapeutic target
  • Journal of Molecular Endocrinology 47 R25–R41 (August 2011)
  • REVIEW: Iñigo Landa and Mercedes Robledo
  • Association studies in thyroid cancer susceptibility: are we on the right track?
  • Journal of Molecular Endocrinology 47 R43–R58 (August 2011)
  • COMMENTARY: Colin Farquharson
  • Social networking between cells of the foetal skeleton: the importance of thyroid hormones
  • Journal of Endocrinology 210 135–136 (August 2011)
  • REVIEW: Giampaolo Trivellin and Márta Korbonits
  • AIP and its interacting partners
  • Journal of Endocrinology 210 137–155 (August 2011)
  • REVIEW: Vicki E Smith, Jayne A Franklyn, and Christopher J McCabe
  • Expression and function of the novel proto-oncogene PBF in thyroid cancer: a new target for augmenting radioiodine uptake
  • Journal of Endocrinology 210 157–163 (August 2011)
  • COMMENTARY: Carol A Lange and Douglas Yee
  • Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer
  • Endocrine-Related Cancer 18 C19–C24 (August 2011)
  • COMMENTARY: Jiyoung Park and Philipp E Scherer
  • Leptin and cancer: from cancer stem cells to metastasis
  • Endocrine-Related Cancer 18 C25–C29 (August 2011)
  • REVIEW: Pamela Bielli, Roberta Busa, Maria Paola Paronetto, and Claudio Sette
  • The RNA-binding protein Sam68 is a multifunctional player in human cancer
  • Endocrine-Related Cancer 18 R91–R102 (August 2011)
  • REVIEW: Kate L Mahon, Susan M Henshall, Robert L Sutherland, and Lisa G Horvath
  • Pathways of chemotherapy resistance in castration-resistant prostate cancer
  • Endocrine-Related Cancer 18 R103–R123 (August 2011)
  • REVIEW: Antonino Belfiore and Roberta Malaguarnera
  • Insulin receptor and cancer
  • Endocrine-Related Cancer 18 R125–R147 (August 2011)
  • COMMENTARY: Hindrik Mulder
  • Matrix metalloproteinases: keys to healthier blood vessels in diabetes?
  • Journal of Endocrinology 210 1–2 (July 2011)
  • COMMENTARY: Marian Ludgate
  • Extrathyroidal thyroid hormone synthesis?
  • Journal of Endocrinology 210 3–4 (July 2011)
  • REVIEW: Mohan Singh, Parvesh Chaudhry, and Eric Asselin
  • Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors
  • Journal of Endocrinology 210 5–14 (July 2011)
  • REVIEW: Jinke Wang, Jie Lu, Guangming Gu, and Yingxun Liu
  • In vitro DNA-binding profile of transcription factors: methods and new insights
  • Journal of Endocrinology 210 15–27 (July 2011)
  • REVIEW: Alberto Pascual, María Hidalgo-Figueroa, Raquel Gómez-Díaz, and José López-Barneo
  • GDNF and protection of adult central catecholaminergic neurons
  • Journal of Molecular Endocrinology 46 R83–R92 (June 2011)
  • REVIEW: Christopher J Romero, Elyse Pine-Twaddell, and Sally Radovick
  • Novel mutations associated with combined pituitary hormone deficiency
  • Journal of Molecular Endocrinology 47 R93–R102 (June 2011)
  • THEMATIC REVIEW: Graham R Williams and J H Duncan Bassett
  • Local control of thyroid hormone action: role of type 2 deiodinase
  • Journal of Endocrinology 209 261–272 (June 2011)
  • THEMATIC REVIEW: Monica Dentice and Domenico Salvatore
  • Local impact of thyroid hormone inactivation
  • Journal of Endocrinology 209 273–282 (June 2011)
  • THEMATIC REVIEW: Ana Luiza Maia, Iuri Martin Goemann, Erika L Souza Meyer, and Simone Magagnin Wajner
  • Type 1 iodothyronine deiodinase in human physiology and disease
  • Journal of Endocrinology 209 283–297 (June 2011)
  • REVIEW: Diego Russo, Giuseppe Damante, Efisio Puxeddu, Cosimo Durante, and Sebastiano Filetti
  • Epigenetics of thyroid cancer and novel therapeutic targets
  • Journal of Molecular Endocrinology 46 R73–R81 (June 2011)
  • COMMENTARY: Mei Dong and James C Yao
  • mTOR inhibition, a potential novel approach for bronchial carcinoids
  • Endocrine-Related Cancer 18 C15–C18 (June 2011)
  • REVIEW: Balaji Ramachandran, Alessia Stell, Luca Maravigna, Adriana Maggi, and Paolo Ciana
  • Novel insights on imaging sex hormone-dependent tumourigenesis in vivo
  • Endocrine-Related Cancer 18 R41–R51 (June 2011)
  • REVIEW: William H Chong, Alfredo A Molinolo, Clara C Chen, and Michael T Collins
  • Tumor-induced osteomalacia
  • Endocrine-Related Cancer 18 R53–R77 (June 2011)
  • REVIEW: Thierry Petit, Patrick Dufour, and Ian Tannock
  • A critical evaluation of the role of aromatase inhibitors as adjuvant therapy for postmenopausal women with breast cancer
  • Endocrine-Related Cancer 18 R79–R89 (June 2011)
  • REVIEW: Soo-Hyun Kim, Jeremy Turnbull, and Scott Guimond
  • Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor
  • Journal of Endocrinology 209 139–151 (May 2011)
  • REVIEW: Femke L Groeneweg, Henk Karst, E Ron de Kloet, and Marian Joëls
  • Rapid non-genomic effects of corticosteroids and their role in the central stress response
  • Journal of Endocrinology 209 153–167 (May 2011)
  • REVIEW: Koichi Suzuki, Akira Kawashima, Aya Yoshihara, Takeshi Akama, Mariko Sue, Akio Yoshida, and Hiroaki J Kimura
  • Role of thyroglobulin on negative feedback autoregulation of thyroid follicular function and growth
  • Journal of Endocrinology 209 169–174 (May 2011)
  • REVIEW: Luis Varela, María J Vÿzquez, Fernando Cordido, Rubén Nogueiras, Antonio Vidal-Puig, Carlos Diéguez, and Miguel López
  • Ghrelin and lipid metabolism: key partners in energy balance
  • Journal of Molecular Endocrinology 46 R43–R63 (April 2011)
  • REVIEW: Matthias Laudes
  • Role of WNT signalling in the determination of human mesenchymal stem cells into preadipocytes
  • Journal of Molecular Endocrinology 46 R65–R72 (April 2011)
  • REVIEW: J Patel, K Landers, H Li, R H Mortimer, and K Richard
  • Thyroid hormones and fetal neurological development
  • Journal of Endocrinology 209 1–8 (April 2011)
  • REVIEW: Bruno Ragazzon, Guillaume Assié, and Jérôme Bertherat
  • Transcriptome analysis of adrenocortical cancers: from molecular classification to the identification of new treatments
  • Endocrine-Related Cancer 18 R15–R27 (April 2011)
  • REVIEW: C Nascimento, I Borget, A Al Ghuzlan, D Deandreis, L Chami, J P Travagli, D Hartl, J Lumbroso, C Chougnet, L Lacroix, E Baudin, M Schlumberger, and S Leboulleux
  • Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
  • Endocrine-Related Cancer 18 R29–R40 (April 2011)
  • REVIEW: Linlin Su, Dolores D Mruk and C Yan Cheng
  • Drug transporters, the blood–testis barrier, and spermatogenesis
  • Journal of Endocrinology 208 207–223 (March 2011)
  • REVIEW: A D Adamson, D Jackson and J R E Davis
  • Novel approaches to in vitro transgenesis
  • Journal of Endocrinology 208 193–206 (March 2011)
  • REVIEW: María Angeles Arevalo, María Santos-Galindo, Natalia Lagunas, Inigo Azcoitia, and Luis M Garcia-Segura
  • Selective estrogen receptor modulators as brain therapeutic agents
  • Journal of Molecular Endocrinology 46 R1–R9 (February 2011)
  • REVIEW: Xiang Zhang and Shuk-Mei Ho
  • Epigenetics meets endocrinology
  • Journal of Molecular Endocrinology 46 R11–R32 (February 2011)
  • REVIEW: Henrik Fagman and Mikael Nilsson
  • Morphogenetics of early thyroid development
  • Journal of Molecular Endocrinology 46 R33–R42 (February 2011)
  • REVIEW: Saira Hameed, Channa N Jayasena and Waljit S Dhillo
  • Kisspeptin and fertility
  • Journal of Endocrinology 208 97–105 (February 2011)
  • COMMENTARY: Debbie L Hay, Christopher S Walker, and David R Poyner
  • Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: opportunities and challenges
  • Endocrine-Related Cancer18 C1–C14 (February 2011)
  • REVIEW: Leigh C Murphy, Srinivas V Seekallu, and Peter H Watson
  • Clinical significance of estrogen receptor phosphorylation
  • Endocrine-Related Cancer18 R1–R14 (February 2011)